AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
AeroRx Therapeutics has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
AeroRx Therapeutics's investors include Correlation Ventures, Alexandria Venture Investments, Avalon BioVentures.
AeroRx Therapeutics is headquartered in La Jolla, United States.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
AeroRx Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AeroRx Therapeutics — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/aerorx-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). AeroRx Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aerorx-therapeutics
{{cite web |title=AeroRx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aerorx-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated